Try GOLD - Free
India-US BTA Talks Throw Up Tricky Farm Riddles to Solve
Business Standard
|July 07, 2025
Any decision on granting access to maize from the US may send the ruling JD(U)-BJP-led coalition back to the drawing board in poll-bound Bihar, writes Sanjeeb Mukherjee
-
As the India-United States (US) Bilateral Trade Agreement (BTA) negotiations enter a crucial phase, the fate of three key agricultural commodities—maize, soybean, and soyoil—would be keenly watched.
According to sources, the US boasts of huge surpluses of all three commodities and is pushing to ease entry barriers as part of the deal. If the US has its way, it could have repercussions for farmers in Madhya Pradesh, Maharashtra, Telangana, and Andhra Pradesh. But, the most immediate impact could be in Bihar, which goes to polls later this year.
Why maize is a big deal in Bihar As of 2024-25 (July to June crop year), maize was grown in around 12 million hectares and soybean in around 13 million hectares across India. Maize is largely cultivated in central and northeastern Bihar—Saharsa, Kishanganj, Khagaria, Araria, and Purnea districts—also known as the Seemanchal region.
Chief Minister Nitish Kumar's Janata Dal (United) and Tejashwi Yadav's Rashtriya Janata Dal (RJD) have held sway over Seemanchal. The JD(U) won most of the seats in Seemanchal in the 2020 Assembly elections. Observers, however, attribute this to the entry of Asaduddin Owaisi-led All India Majlis-e-Ittehadul Muslimeen (AIMIM) that possibly dented RJD's prospects.
Any uncontrolled import of maize, in case the US gets access to the domestic market, could have political ramifications for the JD(U)-BJP-led ruling coalition, say experts.
Key to ethanol blending Maize, integral to Bihar's agro-economy, is India's third-most widely-produced cereal after wheat and rice. Assembly polls are due in Bihar in October-November. This almost coincides with the kharif maize harvesting period in the state as well.
This story is from the July 07, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
